Table 1

Demographics and admission factors of patients attending follow-up (n=110)

CharacteristicMild
(n=27)
Moderate (n=65)Severe
(n=18)
Demographics
Age (18+), years47 (32–61)57 (48–67)62 (54–71)
BAME5 (19%)15 (23%)3 (19%)
Male13 (48%)44 (68%)11 (61%)
BMI (mean)31.232.532.5
Comorbidities
T1DM1 (3.7%)1 (1.5%)1 (5.6%)
T2DM2 (7.4%)12 (18%)2 (11%)
Heart disease6 (22%)11 (17%)3 (17%)
Chronic lung disease4 (15%)16 (25%)8 (44%)
Severe liver disease0 (0%)1 (1.5%)0 (0%)
Severe kidney disease1 (3.7%)4 (6.2%)2 (11%)
Hypertension4 (15%)16 (25%)7 (39%)
HIV0 (0%)0 (0%)1 (5.6%)
Laboratory testing
SARS-CoV-2 PCR+ve
(as inpatient)
21 (78%)50 (77%)10 (56%)
SARS-CoV-2 IgG+ve (Abbott/Roche)
(at follow-up)
18 (67%)56 (86%)15 (83%)
SARS-CoV-2 PCR–ve
(as inpatient) and SARS-CoV-2 IgG–ve (at follow-up)
3 (11%)6 (9%)2 (11%)
Outcomes
Admission NEWS score (IQR)2 (1–3)4 (2–6)5 (4–8)
Radiographic severity score on admission chest radiograph0 (0–2)3 (1.75–4)3 (1.25–6)
Invasive or non-invasive ventilation required0 (0%)0 (0%)16 (89%)
Supplementary oxygen required0 (0%)65 (100%)18 (100%)
Hospital length of stay, days2 (1–4)5 (2–8)10 (7–17)
  • BAME, Black, Asian and minority ethnic; BMI, body mass index; NEWS, National Early Warning Score; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.